Global Smart Asthma Monitoring Market Overview:
Inhaler is the medical device that is used to cure respiratory diseases. Smart inhalers have inbuilt digital sensors that helps in recording the usage of an inhaler at the time of access and provides easier access to the user as it can be connected via Bluetooth to the mobile phone. Smart Inhalers can generate alerts for the daily dosage for the user. Smart Portable Monitoring Device for Asthma Patients helps to track real time symptoms of asthma and to make immediate changes in medications. The developed system overcomes the shortcomings of existing system by patient’s environmental parameters and home monitoring the lung functions over time without any supervision as in standard spirometry test. The proposed system includes portable hardware unit to monitor patient’s activity, carbon dioxide content and exhaled air pressure and environment temperature of the asthma patient.
Growth Drivers
- Increasing prevalence of COPD and Asthma Globally
- Growing Adoption of Smart Medical Devices to Keep Daily Records
Roadblocks
- Accuracy and Reliability of the Device Are Not Known
Opportunities
- Increased Focus towards Advanced Treatment Protocols
- Growing Fad of Smoking Which Leads Respiratory Diseases
Challenges
- An Electronic Monitoring Device May Be Required For More Than One Inhaler per Patient
Competitive Landscape:
Some of the key players profiled in the report are Vectura Group plc (United Kingdom), AstraZeneca (United Kingdom), Teva Pharmaceutical Industries Ltd. (Israel), Adherium Limited (New Zealand), Cohero Health (United States), Philips Healthcare (Netherlands), GlaxoSmithKline plc (United Kingdom), Volansys Technologies (United States), 3M (United States), Novartis AG (Switzerland) and Sunovion Pharmaceuticals Inc. (United States). Additionally, following companies can also be profiled that are part of our coverage like Health Care Originals (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Smart Asthma Monitoring market by 2026. Considering Market by End-Users, the sub-segment i.e. Hospitals will boost the Smart Asthma Monitoring market. Considering Market by Sensors, the sub-segment i.e. Dust Sensor will boost the Smart Asthma Monitoring market.
Latest Market Insights:
On May 09, 2019- Philips has announced collaboration with Medtronic to further advance the image-guided treatment of atrial fibrillation. Through the agreement, Medtronic will facilitate sales of products on behalf of Philips to provide an innovative, integrated image guidance solution for cryoablation procedures.
What Can be Explored with the Smart Asthma Monitoring Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Smart Asthma Monitoring Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Smart Asthma Monitoring
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Smart Asthma Monitoring market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Smart Asthma Monitoring market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Smart Asthma Monitoring, Distributors and Suppliers of Smart Asthma Monitoring, Public and Private Physicians, Clinical Laboratories, Healthcare Institutions and Research Firms.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.